Clinical Trial Update: Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating pharmacist prescribing to improve stroke prevention in atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Snippet

Sponsor: University of Alberta | Conditions: Atrial Fibrillation, Stroke | Phase 4 | Status: COMPLETED